Emerging infectious diseases · 2016
High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
San-Juan Rafael, Viedma Esther, Chaves Fernando, Lalueza Antonio, Fortún Jesús, Loza Elena, Pujol Miquel, Ardanuy Carmen, Morales Isabel, de Cueto Marina, Resino-Foz Elena, Morales-Cartagena Alejandra, Rico Alicia, Romero María P, Orellana María Ángeles, López-Medrano Francisco, Fernández-Ruiz Mario, Aguado José María
Аннотация
We investigated the prognostic role of high MICs for antistaphylococcal agents in patients with methicillin-sensitive Staphylococcus aureus catheter-related bloodstream infection (MSSA CRBSI). We prospectively reviewed 83 episodes from 5 centers in Spain during April 2011-June 2014 that had optimized clinical management and analyzed the relationship between E-test MICs for vancomycin, daptomycin, oxacillin, and linezolid and development of complicated bacteremia by using multivariate analysis. Complicated MSSA CRBSI occurred in 26 (31.3%) patients; MICs for vancomycin and daptomycin were higher in these patients (optimal cutoff values for predictive accuracy = 1.5 μg/mL and 0.5 μg/mL). High MICs for vancomycin (hazard ratio 2.4, 95% CI 1.2-5.5) and daptomycin (hazard ratio 2.4, 95% CI 1.1-5.9) were independent risk factors for development of complicated MSSA CRBSI. Our data suggest that patients with MSSA CRBSI caused by strains that have high MICs for vancomycin or daptomycin are at increased risk for complications.
Предметные рубрики MeSH
Anti-Bacterial AgentsBacteremiaCatheter-Related InfectionsComorbidityDaptomycinDisease ManagementDrug Resistance, BacterialFemaleHumansKaplan-Meier EstimateMaleMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMiddle AgedRisk FactorsSpainStaphylococcal InfectionsTreatment OutcomeVancomycin